Variant report

Variant	esv3338705
Chromosome Location	chr11:74950304-74954802
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:525)
CpG islands
(count:672)
Chromatin interactive
region (count:22)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:525 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:74952687-74952993	K562	blood:	n/a	n/a
2	ARID3A	chr11:74952749-74952918	HepG2	liver:	n/a	n/a
3	ATF3	chr11:74952515-74953036	K562	blood:	n/a	n/a
4	BACH1	chr11:74952712-74952993	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr11:74952116-74952443	H1-hESC	embryonic stem cell:	n/a	n/a
6	BCLAF1	chr11:74952601-74953085	GM12878	blood:	n/a	n/a
7	BHLHE40	chr11:74951388-74951751	K562	blood:	n/a	chr11:74951656-74951672
8	BHLHE40	chr11:74953507-74953603	K562	blood:	n/a	n/a
9	BHLHE40	chr11:74952360-74953143	K562	blood:	n/a	n/a
10	BHLHE40	chr11:74952704-74953043	GM12878	blood:	n/a	n/a
11	BRCA1	chr11:74952733-74952941	H1-hESC	embryonic stem cell:	n/a	n/a
12	BRCA1	chr11:74952719-74952944	HepG2	liver:	n/a	n/a
13	CBX3	chr11:74952649-74953049	K562	blood:	n/a	n/a
14	CBX3	chr11:74952666-74952959	K562	blood:	n/a	n/a
15	CCNT2	chr11:74951808-74953252	K562	blood:	n/a	chr11:74951881-74951890
16	CEBPB	chr11:74952788-74952979	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr11:74952796-74952979	HepG2	liver:	n/a	n/a
18	CEBPB	chr11:74952657-74953004	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD1	chr11:74952841-74952970	GM12878	blood:	n/a	n/a
20	CHD1	chr11:74952511-74953352	IMR90	lung:	n/a	n/a
21	CHD2	chr11:74952628-74953081	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD2	chr11:74952734-74952972	HepG2	liver:	n/a	n/a
23	CHD2	chr11:74952665-74952899	K562	blood:	n/a	n/a
24	CHD2	chr11:74952652-74952961	GM12878	blood:	n/a	n/a
25	CHD2	chr11:74952824-74952958	Hela-S3	cervix:	n/a	n/a
26	CREB1	chr11:74952025-74953166	HepG2	liver:	n/a	n/a
27	CREB1	chr11:74952592-74953102	H1-hESC	embryonic stem cell:	n/a	n/a
28	CREB1	chr11:74952089-74952501	H1-hESC	embryonic stem cell:	n/a	n/a
29	CREB1	chr11:74952301-74953102	A549	lung:	n/a	n/a
30	CTBP2	chr11:74951385-74953406	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr11:74952780-74952930	AG04450	lung:	n/a	n/a
32	CTCF	chr11:74952567-74953031	HepG2	liver:	n/a	n/a
33	CTCF	chr11:74952800-74952950	GM12870	blood:	n/a	n/a
34	CTCF	chr11:74952436-74952444	Fibrobl	skin:	n/a	n/a
35	CTCF	chr11:74952780-74952930	HCM	heart:	n/a	n/a
36	CTCF	chr11:74952668-74953049	K562	blood:	n/a	n/a
37	CTCF	chr11:74952740-74952890	MCF-7	breast:	n/a	n/a
38	CTCF	chr11:74952760-74952910	GM06990	blood:	n/a	n/a
39	CTCF	chr11:74952780-74952930	BJ	skin:	n/a	n/a
40	CTCF	chr11:74952760-74952910	GM12864	blood:	n/a	n/a
41	CTCF	chr11:74952465-74952473	GM19239	blood:	n/a	n/a
42	CTCF	chr11:74952740-74952890	HCT-116	colon:	n/a	n/a
43	CTCF	chr11:74952680-74952988	A549	lung:	n/a	n/a
44	CTCF	chr11:74952760-74952910	K562	blood:	n/a	n/a
45	CTCF	chr11:74952701-74953003	GM20000	blood:	n/a	n/a
46	CTCF	chr11:74952760-74952910	HCT-116	colon:	n/a	n/a
47	CTCF	chr11:74952720-74952870	HFF-Myc	foreskin:	n/a	n/a
48	CTCF	chr11:74952780-74952930	RPTEC	kidney:	n/a	n/a
49	CTCF	chr11:74952740-74952890	HEK293	kidney:	n/a	n/a
50	CTCF	chr11:74952693-74953027	GM13976	blood:	n/a	n/a

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:74954620-74954670	HCM	heart:	n/a
2	chr11:74954620-74954670	HCM	heart:	n/a
3	chr11:74951179-74951229	MCF10A-Er-Src	breast:	n/a
4	chr11:74950764-74950814	HepG2	liver:	n/a
5	chr11:74952790-74952840	AoSMC	blood vessel:	n/a
6	chr11:74950764-74950814	PANC-1	pancreas:	n/a
7	chr11:74951179-74951229	AoSMC	blood vessel:	n/a
8	chr11:74950764-74950814	Caco-2	colon:	n/a
9	chr11:74952787-74952837	NT2-D1	testis:	n/a
10	chr11:74950764-74950814	MCF-7	breast:	n/a
11	chr11:74952787-74952837	HCM	heart:	n/a
12	chr11:74951359-74951409	GM12891	blood:	n/a
13	chr11:74952787-74952837	HCF	heart:	n/a
14	chr11:74951179-74951229	HNPCEpiC	eye:	n/a
15	chr11:74951179-74951229	AG04450	lung:	fetal
16	chr11:74951923-74951973	HRCEpiC	kidney:	n/a
17	chr11:74951359-74951409	HRE	kidney:	n/a
18	chr11:74953490-74953540	MCF10A-Er-Src	breast:	n/a
19	chr11:74951923-74951973	IMR90	lung:	fetal
20	chr11:74952790-74952840	HRCEpiC	kidney:	n/a
21	chr11:74954620-74954670	HepG2	liver:	n/a
22	chr11:74952165-74952215	NHDF-neo	bronchial:	n/a
23	chr11:74951923-74951973	SAEC	small airway:	n/a
24	chr11:74953082-74953132	AG04450	lung:	fetal
25	chr11:74953082-74953132	NHDF-neo	bronchial:	n/a
26	chr11:74953082-74953132	MCF10A-Er-Src	breast:	n/a
27	chr11:74952787-74952837	AG04450	lung:	fetal
28	chr11:74950396-74950446	AG10803	skin:	n/a
29	chr11:74951923-74951973	HCT-116	colon:	n/a
30	chr11:74952165-74952215	AG10803	skin:	n/a
31	chr11:74951359-74951409	SK-N-SH	brain:	n/a
32	chr11:74952165-74952215	BE2_C	brain:	n/a
33	chr11:74952790-74952840	GM19239	blood:	n/a
34	chr11:74952787-74952837	RPTEC	kidney:	n/a
35	chr11:74951359-74951409	AG10803	skin:	n/a
36	chr11:74951923-74951973	T-47D	breast:	n/a
37	chr11:74951179-74951229	HRE	kidney:	n/a
38	chr11:74950764-74950814	HPAEpiC	pulmonary alveolar:	n/a
39	chr11:74951359-74951409	SK-N-MC	brain:	n/a
40	chr11:74954620-74954670	Jurkat	blood:	n/a
41	chr11:74952787-74952837	K562	blood:	n/a
42	chr11:74952165-74952215	BJ	skin:	n/a
43	chr11:74952165-74952215	NHBE	bronchial:	n/a
44	chr11:74952787-74952837	HAEpiC	amniotic membrane:	n/a
45	chr11:74952790-74952840	GM06990	blood:	n/a
46	chr11:74952787-74952837	NHBE	bronchial:	n/a
47	chr11:74951923-74951973	PANC-1	pancreas:	n/a
48	chr11:74952787-74952837	HL-60	blood:	n/a
49	chr11:74952165-74952215	MCF10A-Er-Src	breast:	n/a
50	chr11:74954620-74954670	GM12892	blood:	n/a

(count:22 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:74855250..74856195-chr11:74952793..74953318,2	K562	blood:
2	chr11:74953050..74955146-chr11:75048496..75050415,2	K562	blood:
3	chr11:74925000..74926013-chr11:74952324..74953354,12	MCF-7	breast:
4	chr11:74925158..74925973-chr11:74952278..74953089,3	K562	blood:
5	chr11:74915518..74916204-chr11:74952277..74953016,2	MCF-7	breast:
6	chr11:74733402..74734825-chr11:74952350..74953292,7	K562	blood:
7	chr11:74952768..74954538-chr11:74955270..74959114,3	K562	blood:
8	chr11:74952321..74952936-chr12:76424646..76425589,2	HCT-116	colon:
9	chr11:74733622..74734624-chr11:74952400..74953312,9	MCF-7	breast:
10	chr11:74930581..74931130-chr11:74952289..74952870,2	K562	blood:
11	chr11:74855244..74856442-chr11:74952713..74953475,5	MCF-7	breast:
12	chr11:74920713..74922645-chr11:74953043..74955609,2	MCF-7	breast:
13	chr11:74657727..74660130-chr11:74951983..74953797,2	K562	blood:
14	chr11:74735572..74736278-chr11:74952296..74952887,2	K562	blood:
15	chr11:74952691..74953296-chr11:75095152..75095848,2	K562	blood:
16	chr11:74659830..74661713-chr11:74952303..74954332,2	MCF-7	breast:
17	chr11:74924673..74926005-chr11:74952370..74953068,4	MCF-7	breast:
18	chr11:74660462..74662157-chr11:74951131..74952954,2	K562	blood:
19	chr11:74733768..74734574-chr11:74952444..74953243,2	MCF-7	breast:
20	chr11:74923854..74925700-chr11:74949115..74951246,2	K562	blood:
21	chr11:74742652..74743217-chr11:74952410..74953405,2	K562	blood:
22	chr11:74640083..74642436-chr11:74952777..74954746,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ARRB1-1	chr11:74952051-74952092	ENSG00000255136.2
2	lnc-ARRB1-1	chr11:74952051-74952218	ENSG00000255136.1

No data

Variant related genes	Relation type
ENSG00000255136	TF binding region
TPBGL	TF binding region
ENSG00000255136	CpG island
TPBGL	CpG island
ENSG00000139289	chromatin interactions
ENSG00000118363	chromatin interactions
ENSG00000166435	chromatin interactions

Extended variants
information (count: 137 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:137 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536331384	chr11:74950329-74950330	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs553459788	chr11:74950340-74950341	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs7943934	chr11:74950347-74950348	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs534854146	chr11:74950442-74950443	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs186909176	chr11:74950446-74950447	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs577978768	chr11:74950494-74950495	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs543717586	chr11:74950509-74950510	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs563123003	chr11:74950515-74950516	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs573610921	chr11:74950543-74950544	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs542357737	chr11:74950588-74950589	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs369566910	chr11:74950643-74950644	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs143761657	chr11:74950662-74950663	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs368351928	chr11:74950665-74950666	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs528179745	chr11:74950746-74950747	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs192477834	chr11:74950808-74950809	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs72998593	chr11:74950897-74950898	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs541921340	chr11:74950936-74950937	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs551292918	chr11:74950976-74950977	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs567531983	chr11:74951095-74951096	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs536697857	chr11:74951096-74951097	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs185092987	chr11:74951097-74951098	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs148147627	chr11:74951104-74951105	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs539157887	chr11:74951133-74951134	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs557949251	chr11:74951135-74951136	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs189798256	chr11:74951151-74951152	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs557605847	chr11:74951186-74951187	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs7927563	chr11:74951191-74951192	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs372988684	chr11:74951234-74951235	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs376991311	chr11:74951241-74951242	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs142622341	chr11:74951303-74951304	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs575868229	chr11:74951314-74951315	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs573545638	chr11:74951320-74951321	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs542566086	chr11:74951325-74951326	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs552550203	chr11:74951328-74951329	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs369791319	chr11:74951356-74951357	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs193161366	chr11:74951367-74951368	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs572578462	chr11:74951377-74951378	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs74495577	chr11:74951417-74951418	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs565124024	chr11:74951426-74951427	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs531164080	chr11:74951444-74951445	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs184600776	chr11:74951460-74951461	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs561667078	chr11:74951493-74951494	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs530336852	chr11:74951508-74951509	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs7927925	chr11:74951534-74951535	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs545014302	chr11:74951540-74951541	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs566887469	chr11:74951564-74951565	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs376212661	chr11:74951566-74951567	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs80061879	chr11:74951568-74951569	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs563132958	chr11:74951588-74951589	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs77276998	chr11:74951620-74951621	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Glioblastoma multiforme	21080181	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Melanoma	18172304	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
lymphocytic leukemia	21291569	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	16620391	CNVD
Multiple myeloma	17550852	CNVD
Neuroblastoma	18923191	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21482786	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	16608533	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:471 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:74945400-74951600	Weak transcription	Ovary	ovary
2	chr11:74948600-74950400	Weak transcription	Brain Anterior Caudate	brain
3	chr11:74950000-74951200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr11:74950200-74950400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
5	chr11:74950200-74950400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr11:74950200-74951200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
7	chr11:74950200-74951200	Enhancers	H9 Cell Line	embryonic stem cell
8	chr11:74950400-74950600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
9	chr11:74950400-74950600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
10	chr11:74950400-74950600	Enhancers	Brain Anterior Caudate	brain
11	chr11:74950400-74951000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
12	chr11:74950400-74951000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
13	chr11:74950400-74951200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
14	chr11:74950600-74950800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
15	chr11:74950600-74951000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
16	chr11:74950600-74951000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
17	chr11:74950600-74951000	Weak transcription	Brain Anterior Caudate	brain
18	chr11:74950600-74951200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr11:74950600-74951400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr11:74950800-74951200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
21	chr11:74951000-74951200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
22	chr11:74951000-74951200	Bivalent/Poised TSS	Primary T helper cells PMA-I stimulated	--
23	chr11:74951000-74951400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr11:74951000-74951400	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr11:74951000-74951400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
26	chr11:74951000-74951400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
27	chr11:74951000-74951400	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr11:74951000-74951400	Bivalent Enhancer	Brain Germinal Matrix	brain
29	chr11:74951000-74951400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
30	chr11:74951000-74951400	Bivalent Enhancer	Fetal Stomach	stomach
31	chr11:74951000-74951600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
32	chr11:74951000-74952200	Enhancers	Spleen	Spleen
33	chr11:74951000-74953200	Active TSS	Brain Anterior Caudate	brain
34	chr11:74951000-74953400	Active TSS	Brain Angular Gyrus	brain
35	chr11:74951000-74953600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
36	chr11:74951200-74951400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
37	chr11:74951200-74951400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
38	chr11:74951200-74951400	Flanking Bivalent TSS/Enh	H9 Cell Line	embryonic stem cell
39	chr11:74951200-74951400	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr11:74951200-74951400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
41	chr11:74951200-74951400	Bivalent/Poised TSS	Primary T helper memory cells from peripheral blood 2	blood
42	chr11:74951200-74951400	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
43	chr11:74951200-74951400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
44	chr11:74951200-74951400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
45	chr11:74951200-74951400	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
46	chr11:74951200-74951400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
47	chr11:74951200-74951400	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
48	chr11:74951200-74951400	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
49	chr11:74951200-74951400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr11:74951200-74951400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links